A Major Milestone in Consumer Health Empowerment
Today, 23andMe received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk for its BRCA1/BRCA2 (Selected Variants) report.
Today, 23andMe received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk for its BRCA1/BRCA2 (Selected Variants) report.
Just in time for New Year’s resolutions, 23andMe is embarking on a first-of-its-kind study that will engage with customers to learn more about genetic variants associated with weight loss, and the effectiveness of using different diets or exercise to lose weight.
ZDogg — aka Dr. Zubin Damania, a doctor and a hip-hop humorist of healthcare — was in the house at 23andMe last week, for a conversation with our CEO and co-founder Anne Wojcicki for his Facebook Live show, Incident Report.
This week 23andMe released a new genetic health risk report on celiac disease that looks at two genetic variants — rs2187668 and rs7454108 — that are linked to the HLA-DQ2.5 and HLA-DQ8 haplotypes.
The annual meeting of the American Society of Human Genetics kicks off in Orlando this October packed with five days of seminars, panel discussions, talks, and presentations that are all part of an event that might best be described as the Coachella (or Woodstock if you prefer) of genetics.
In a first-of-its-kind study, researchers at 23andMe found a link between the susceptibility for some of the most common infectious diseases and dozens of specific variants in genes involved in the body’s frontline immune response system.
A new survey found that most Americans are interested in using DNA testing to understand more about their health and ancestry, but the national survey also revealed a need for better education around the science of genetics.
For the first time, researchers have identified genetic variants that put some women at a higher risk of having a premature baby — findings that may ultimately help scientists prevent what is the leading cause of childhood mortality worldwide.
Last week, 23andMe released two new genetic health risk reports for customers.
23andMe recently started offering customers new Genetic Health Risk reports that have received FDA authorization. Below we’ve highlighted some important features in these reports to help you get more out of them.